# EDGAR Filing Document

**Accession Number:** 0001666071
**File Stem:** 0001628280-26-014661
**Filing Date:** 2026-3
**Character Count:** 20573
**Document Hash:** 69ced7144d18572502918ea6185d9e83
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-014661.hdr.sgml**: 20260304

**ACCESSION NUMBER**: 0001628280-26-014661

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260304

**DATE AS OF CHANGE**: 20260304

**EFFECTIVENESS DATE**: 20260304

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cardlytics, Inc.
- **CENTRAL INDEX KEY:** 0001666071
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 263039436
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294015
- **FILM NUMBER:** 26721991

**BUSINESS ADDRESS:**
- **STREET 1:** 675 PONCE DE LEON AVENUE, NE
- **STREET 2:** SUITE 4100
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30308
- **BUSINESS PHONE:** 888-798-5802

**MAIL ADDRESS:**
- **STREET 1:** 675 PONCE DE LEON AVENUE, NE
- **STREET 2:** SUITE 4100
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30308

**As filed with the Securities and Exchange Commission on March 4, 2026**

Registration No. 333-

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

![cardlytics_logoa12a.jpg](cardlytics_logoa12a.jpg)

---

| |
|:---|
| **CARDLYTICS, INC.** |
| (Exact Name of Registrant as Specified in its Charter) |

---

---

| | | |
|:---|:---|:---|
| | **675 Ponce de Leon Avenue NE, Suite 4100** | |
| **Delaware** | **Atlanta, Georgia 30308** | **26-3039436** |
| (State or other jurisdiction of <br>incorporation or organization) | (Address of principal executive offices) (Zip code) | (I.R.S. Employer<br>Identification No.) |

---

---

| |
|:---|
| **2018 Employee Stock Purchase Plan** |
| (Full title of the plan) |
| **Amit Gupta** |
| **Cardlytics, Inc.** |
| **675 Ponce de Leon Avenue NE, Suite 4100** |
| **Atlanta, Georgia 30308** |
| (Name and address of agent for service) |
| **(888) 798-5802** |
| (Telephone number, including area code, of agent for service) |

---

***Copies to:***

**Mark Ballantyne**

**Trey Reilly**

**Cooley LLP**

**One Freedom Square**

**Reston Town Center**

**11951 Freedom Drive**

**Reston, VA 20190**

**(703) 456-8000**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐

------

**EXPLANATORY NOTE**

Pursuant to General Instruction E of Form S-8, Cardlytics, Inc. (the "Registrant") is filing this Registration Statement with the Securities and Exchange Commission (the "Commission") to register 500,000 additional shares of its common stock under the 2018 Employee Stock Purchase Plan (the "2018 ESPP"), pursuant to the provisions of the 2018 ESPP providing for an automatic increase in the number of shares of common stock reserved and available for issuance under the 2018 ESPP on January 1, 2026. In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of the Form S-8 has been omitted from this Registration Statement.

**PART II**

**ITEM 3.**&nbsp;&nbsp;&nbsp;&nbsp;**INCORPORATION OF DOCUMENTS BY REFERENCE**

The following documents filed by the Registrant with the Commission are incorporated by reference into this Registration Statement:

(a) The Registrant's Registration Statements on Form S-8 related to the 2018 ESPP, previously filed with the Commission on February 9, 2018 (<u>[File No. 333-222965](https://www.sec.gov/Archives/edgar/data/1666071/000119312518038098/d538622ds8.htm)</u>), May 21, 2019 (<u>[File No. 333-231640](https://www.sec.gov/Archives/edgar/data/1666071/000166607119000047/cdlx_2019evergreenpoolincr.htm)</u>), March 3, 2020 (<u>[File No. 333-236869](https://www.sec.gov/Archives/edgar/data/1666071/000166607120000055/cdlx_2020evergreenpoolincr.htm)</u>), March 1, 2021 (<u>[File No. 333-253675](https://www.sec.gov/Archives/edgar/data/1666071/000166607121000025/cdlx_2021evergreenpoolincr.htm)</u>), March 1, 2022 (<u>[File No. 333-263143](https://www.sec.gov/Archives/edgar/data/1666071/000166607122000017/cdlx_2022evergreenpoolincr.htm)</u>), January 23, 2023 (<u>[File No. 333-269361](https://www.sec.gov/Archives/edgar/data/1666071/000166607123000018/cdlx_2023evergreenpoolincr.htm)</u>), January 29, 2024 (<u>[File No. 333-276737](https://www.sec.gov/Archives/edgar/data/1666071/000166607124000024/cdlx_2024evergreenpoolincr.htm)</u>) and January 23, 2025 (<u>[File No. 333-284434](https://www.sec.gov/Archives/edgar/data/1666071/000166607125000014/cdlx_2025evergreenpoolincr.htm)</u>).

(b) The Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Commission on <u>[March 4, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001666071/000166607126000010/cdlx-20251231.htm)</u>.

(c) The Registrant's Current Reports on Form 8-K filed with the Commission on <u>[J](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001666071/000166607126000003/cdlx-20260123.htm)[anuary 26, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001666071/000166607126000003/cdlx-20260123.htm)</u>.

(d) The description of the Registrant's Common Stock which is contained in the Registrant's Registration Statement on Form 8-A filed on <u>[February 6, 2018](https://www.sec.gov/Archives/edgar/data/1666071/000119312518032678/d535325d8a12b.htm)</u> (File No. 001-38386) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including any amendment or report filed for the purpose of updating such description, including Exhibit 4.3 to the Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the Commission on <u>[March 3, 2020](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001666071/000166607120000054/cdlxform10-k2019.htm)</u>.

(e) All other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

**ITEM 8.**&nbsp;&nbsp;&nbsp;&nbsp;**EXHIBITS**

---

| | | |
|:---|:---|:---|
| **Exhibit Number** | **Exhibit Number** | **Description** |
| 4.1 | (1) | <u>[Amended and Restated Certificate of Incorporation of the Registrant](https://www.sec.gov/Archives/edgar/data/1666071/000119312518010003/d338035dex32.htm)</u> |
| 4.2 | (2) | <u>[Amended and Restated Bylaws of the Registrant](https://www.sec.gov/Archives/edgar/data/1666071/000119312518010003/d338035dex34.htm)</u> |
| 4.4 | (3) | <u>[2018 Employee Stock Purchase Plan](https://www.sec.gov/Archives/edgar/data/1666071/000119312518022400/d338035dex103.htm)</u> |
| 4.5 | (4) | <u>[Specimen stock certificate evidencing shares of Common Stock](https://www.sec.gov/Archives/edgar/data/1666071/000119312518022400/d338035dex41.htm)</u> |
| 5.1 | (5) | <u>[Opinion of Cooley LLP](cardlytics-cooley51opinion.htm)</u> |
| 23.1 | (5) | <u>[Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm](a231deloitteconsent_2026.htm)</u> |
| 23.2 | (5) | <u>[Consent of Cooley LLP (included in Exhibit 5.1)](cardlytics-cooley51opinion.htm)</u> |
| 24.1 | (5) | <u>[Power of Attorney (included on the signature page of this Form S-8)](#i3f453cdcebd24ff99be3956514835a5a_16)</u> |
| 107 | (5) | <u>[Filing Fee Table](exfilingfees.htm)</u> |

---

(1)Previously filed as Exhibit 3.2 to the Registrant's Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 12, 2018, and incorporated by reference herein.

(2)Previously filed as Exhibit 3.4 to the Registrant's Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 12, 2018, and incorporated by reference herein.

(3)Previously filed as Exhibit 10.3 to Amendment No. 1 to the Registrant's Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 29, 2018, and incorporated by reference herein.

(4)Previously filed as Exhibit 4.1 to Amendment No. 1 to the Registrant's Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 29, 2018, and incorporated by reference herein.

(5)Filed herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on March 4, 2026.

---

| | |
|:---|:---|
| CARDLYTICS, INC. | CARDLYTICS, INC. |
| By: | /s/ Amit Gupta |
|  | Amit Gupta |
|  | *Chief Executive Officer* |

---

**POWER OF ATTORNEY**

Know All Persons By These Presents, that each person whose signature appears below constitutes and appoints Amit Gupta, Nick Lynton and David Evans, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

------

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Amit Gupta | Chief Executive Officer and Director | March 4, 2026 |
| Amit Gupta | (Principal Executive Officer) |  |
| /s/ David Evans | Chief Financial Officer | March 4, 2026 |
| David Evans | *(Principal Financial and Accounting Officer)* |  |
| /s/ John Klinck | Chairperson | March 4, 2026 |
| John Klinck |  |  |
| /s/ Jon Francis | Director | March 4, 2026 |
| Jon Francis |  |  |
| /s/ Andre Fernandez | Director | March 4, 2026 |
| Andre Fernandez |  |  |
| /s/ Srishti Gupta | Director | March 4, 2026 |
| Srishti Gupta |  |  |
| /s/ Scott Hill | Director | March 4, 2026 |
| Scott Hill |  |  |
| /s/ Liane Hornsey | Director | March 4, 2026 |
| Liane Hornsey |  |  |
| /s/ Alex Mishurov | Director | March 4, 2026 |
| Alex Mishurov |  |  |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? exfilingfees

&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| **S-8**  |
| **Cardlytics, Inc.**  |

---

**Table 1: Newly Registered Securities** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Security Type**  | **Security Class Title**  | **Fee Calculation Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| 1 | Equity | Common Stock, $0.0001 par value per share, 2018 Employee Stock Purchase Plan | Other | 500000 | $0.7527 | $376338.00 | 0.0001381 | $51.98 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $376338.00 |  | $51.98 |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $— |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $51.98 |

---

<br>**Offering Note** <br>

---

| | |
|:---|:---|
| 1  | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of common stock of Cardlytics, Inc. (the "Registrant") that become issuable under the Registrant's 2018 Employee Stock Purchase Plan (the "2018 ESPP") by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the Registrant's common stock, as applicable. The amount registered represents additional shares of common stock reserved for future issuance under the 2018 ESPP. The proposed maximum offering price per unit and proposed maximum aggregate offering price are estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) promulgated under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are calculated using the average of the high and low prices of the Registrant's common stock as reported on the Nasdaq Global Market on February 26, 2026 multiplied by 85%, which is the percentage of the price per share applicable to purchases under the 2018 ESPP. |

---

------

---

| | |
|:---|:---|
| **Table 2: Fee Offset Claims and Sources** | **☑Not Applicable**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Registrant or Filer Name** | **Form or Filing Type** | **File Number** | **Initial Filing Date** | **Filing Date** | **Fee Offset Claimed** | **Security Type Associated with Fee Offset Claimed** | **Security Title Associated with Fee Offset Claimed** | **Unsold Securities Associated with Fee Offset Claimed** | **Unsold Aggregate Offering Amount Associated with Fee Offset Claimed** | **Fee Paid with Fee Offset Source** |
| **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  | **Rule 457(p)**  |
| Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fee Offset Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---

## Exhibit 5.1

![image_1.jpg](image_1.jpg)

Mark Ballantyne+1 703 456 8084mballantyne@cooley.com EXHIBIT 5.1

March 4, 2026

Cardlytics, Inc.

675 Ponce de Leon Avenue NE, Suite 4100

Atlanta, Georgia 30308

Ladies and Gentlemen:

You have requested our opinion, as counsel to Cardlytics, Inc., a Delaware corporation (the "***Company***"), in connection with the filing by the Company of a Registration Statement on Form S-8 (the "***Registration Statement***") with the Securities and Exchange Commission (the "***Commission***") covering the offering of up to 500,000 shares (the "***Shares***") of the Company's Common Stock, par value $0.0001 per share ("***Common Stock***"), pursuant to the Company's 2018 Employee Stock Purchase Plan (the "***Plan***").

In connection with this opinion, we have examined and relied upon (a) the Registration Statement and the related prospectuses, (b) the Company's certificate of incorporation and bylaws, each as currently in effect, (c) the Plan, and (d) such other records, documents, opinions, certificates, memoranda and instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters.

Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Plan, the Registration Statement and the related prospectuses, will be validly issued, fully paid and nonassessable (except as to shares issued pursuant to deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).

This opinion is limited to the matters expressly set forth in this letter, and no opinion should be implied, or may be inferred, beyond the matters expressly stated. This opinion speaks only as to law and facts in effect or existing as of the date hereof, and we have no obligation or responsibility to update or supplement this opinion to reflect any facts or circumstances that may hereafter come to our attention or any changes in law that may hereafter occur.

\*\*\*\*\*

Cooley LLP Reston Town Center Reston, VA 20190-5656<br>t: (703) 456 8000 f: (703) 456 8100 cooley.com<br>

------

![image_1.jpg](image_1.jpg)

<br> <br> <br> March 4, 2026Page Two <br>

We consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

Sincerely,

Cooley LLP

By: <u>/s/ Mark Ballantyne&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;Mark Ballantyne

Cooley LLP Reston Town Center Reston, VA 20190-5656<br>t: (703) 456 8000 f: (703) 456 8100 cooley.com<br>

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM** 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated March 4, 2026 relating to the consolidated financial statements of Cardlytics, Inc. and subsidiaries (the "Company") and the effectiveness of the Company's internal control over financial reporting appearing in the Annual Report on Form 10-K of Cardlytics, Inc. for the year ended December 31, 2025.

Atlanta, Georgia

March 4, 2026

<br>